Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion type Assertion NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_head.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion description "[While MDS was only recently viewed as an orphan disease without any FDA approved therapeutic options, the landscape has changed dramatically with a promise for development of exciting new therapeutics that parallels our growing understanding of the pathobiology of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_provenance.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion evidence source_evidence_literature NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_provenance.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion SIO_000772 22959510 NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_provenance.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion wasDerivedFrom befree-20150227 NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_provenance.
- NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_assertion wasGeneratedBy ECO_0000203 NP873307.RAlskUloI4vZ9dGBC54b0Lh5Qtg5IYs_2uqFbIeEq1N3E130_provenance.